全髋关节翻修术后死亡率分析
本研究基于2012至2018年596例全髋关节翻修术患者,通过医疗记录及死亡索引查询死亡状态与翻修指征。总体2年死亡率为每1000例19.5例死亡(1/51),假体周围骨折患者2年死亡率显著更高(每1000例74.5例,1/13,P < .001),脱位/不稳为每1000例50.3例(1/20)但差异无统计学意义(P = .531)。
要点
- 全髋翻修术后总体2年死亡率为19.5/1000(1/51)。
- 假体周围骨折翻修者2年死亡率74.5/1000(1/13),显著升高(P < .001)。
- 脱位/不稳翻修者2年死亡率50.3/1000(1/20),差异无统计学意义(P = .531)。
核心结论
- 全髋翻修术后总体2年死亡率为每1000例19.5例死亡,主要归因于假体周围骨折患者(每1000例74.5例),其他翻修指征未显著影响死亡率。
研究设计与样本
- 机构数据库回顾性识别2012至2018年接受全髋关节翻修术的596例患者,查询医疗记录及国家、州、地方死亡索引获取死亡状态与翻修指征。
主要发现
- 总体2年死亡率为每1000例19.5例死亡(1/51)。
- 假体周围骨折患者2年死亡率为每1000例74.5例死亡(1/13),显著高于总体(P < .001)。
- 脱位/不稳患者2年死亡率为每1000例50.3例死亡(1/20),差异无统计学意义(P = .531)。
- 机械松动或感染等其他指征的死亡率无显著差异。
临床怎么用
- 翻修术前咨询应告知总体2年死亡率及不同翻修指征对应的死亡率,尤其假体周围骨折患者死亡率显著更高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In counseling patients about the complications of revision total hip arthroplasty (revTHA), it is imperative that mortality be considered. The actual mortality rate by indication of revision is ill-defined. The purpose of this study is to determine the mortality rate after revTHA. METHODS: An institutional database identified 596 patients who had undergone revTHA between 2012 and 2018. Medical records, national, state, and local death indexes were queried for mortality status and indication for revTHA. For survivors, the last clinical visit date was used for censoring in the mortality analysis. Mortality rates were calculated for all clinical patients and then by specific indication for revision. RESULTS: The overall 2-year mortality rate following revTHA was 19.5 deaths per 1000 or 1 in 51 patients. Patients presenting with a periprosthetic fracture had a significantly higher 2-year mortality rate of 74.5 deaths per 1000 or 1 in 13 patients (P < .001), while an indication of dislocation or instability had a slightly higher 2-year mortality rate of 50.3 per 1000 (1 in 20) but this difference was not significant (P = .531). Other indications such as mechanical loosening or infection did not have a significantly different mortality rate. CONCLUSION: The overall 2-year mortality rate following revTHA was 19.5 deaths per 1000 which was largely attributed to patients with a periprosthetic fracture (74.5 per 1000) with other indications not significantly impacting mortality. Mortality rates and specific rates by indication for revision should be considered when counseling patients prior to revTHA.
引用
- Laughlin MS, Vidal EA, Drtil AA, et al. Mortality After Revision Total Hip Arthroplasty. J Arthroplasty. 2021. PMID: 33558045. doi:10.1016/j.arth.2021.01.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。